Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-morphine monoclonal antibody, cell strain for generating anti-morphine monoclonal antibody, morphine detection kit and manufacturing method thereof

A monoclonal antibody and kit technology, applied in the biological field, can solve the problems of inconvenient sampling, late window period, dirty samples, etc., and achieve the effect of detection limit advantage, strong affinity and high specificity

Active Publication Date: 2014-05-28
HANGZHOU CLONGENE BIOTECH
View PDF2 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patented technology uses different techniques to create modified forms of opium called methoxyborylate (MOB) or acetylenesulfonimide (ASI). These modifications can be made without affecting their function or properties during manufacturing processes. By adding these modifying agents at certain sites on the molecule they improve stability while also making them easier to produce. Additionally, this modification allows for increased efficiency when producing large amounts of pure labeled material compared to previous methods such as ELISA. Overall, this innovative technique simplifies the purification step required before obtaining desired materials from natural sources.

Problems solved by technology

This patented describes different methods or techniques for identifying substances called morphines from liquids found naturally throughout life without causing harmful side effects. These include collectors made up of natural materials like salt solutions, but they also contain chemical compounds associated with their effectiveness. Additionally, these processes involve extracting specific parts of tissues containing certain components through various means, resulting in contamination issues. Therefore, current analyte assays require complicated steps involving multiple fluorescence tests before results may appear positive. There is currently no suitable solution available due to lack of sufficient accuracy and ease of administration during emergency situations.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-morphine monoclonal antibody, cell strain for generating anti-morphine monoclonal antibody, morphine detection kit and manufacturing method thereof
  • Anti-morphine monoclonal antibody, cell strain for generating anti-morphine monoclonal antibody, morphine detection kit and manufacturing method thereof
  • Anti-morphine monoclonal antibody, cell strain for generating anti-morphine monoclonal antibody, morphine detection kit and manufacturing method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Embodiment 1: Preparation of morphine artificial antigen

[0042]

[0043] The above formula is the synthetic route of morphine artificial antigen.

[0044] 1-1. Preparation of morphine hapten: use morphine hydrochloride as raw material, carry out nucleophilic substitution reaction with ethyl bromoacetate after dissociation, and obtain carboxyl-containing morphine hapten.

[0045] Dissolve 350mg of morphine hydrochloride in 10ml of water, adjust the pH to 10 with concentrated ammonia water, a large amount of solids precipitate, place it at 4°C for 30 minutes, and centrifuge at 10,000 rpm to remove the clear liquid The water and ethanol were transferred to a round bottom flask, and concentrated under reduced pressure at 50°C to obtain 288 mg of white solid morphine.

[0046] In a 100ml three-necked flask, 285mg (1mmol) of morphine and 10ml of DMF were added, and under nitrogen protection, 330mg (2.4mmol) of potassium carbonate and 184mg (1.1mmol) of ethyl 4-bromoacet...

Embodiment 2

[0050] Example 2: Screening of anti-morphine monoclonal antibody hybridoma cell lines

[0051] Step (1) mouse immunization

[0052] Morphine artificial antigen, Freund's adjuvant, and 3% Tween-80 saline were mixed according to the volume of 1:1:1 to obtain emulsion by stirring method. Select 8-week-old BALB / c female mice for subcutaneous immunization combined with intrasplenic and intravenous immunization for a total of 5 immunizations. The immunization time is the 1st day, the 14th day, the 21st day, the 22nd day, and the 23rd day. The specific steps Eight-week-old BALB / c female mice were immunized for the first time, and 50 μg of morphine artificial antigen emulsion (complete Freund's adjuvant was used as the adjuvant) was injected into the subcutaneous part near the lymph nodes; for the second intrasplenic immunization, Morphine artificial antigen emulsion with an immune dose of 20 μg (incomplete Freund’s adjuvant is used as an adjuvant); the third, fourth, and fifth times...

Embodiment 3

[0078] Example 3: Performance testing of anti-morphine monoclonal antibody

[0079]3.1 Anti-morphine monoclonal antibody subtype identification

[0080] The subtype of the anti-morphine monoclonal antibody prepared in Example 1 was identified with reference to the monoclonal antibody typing kit. The anti-morphine monoclonal antibody belonged to IgG1 subtype, and the light chain was kappa chain.

[0081] 3.2 Determination of affinity constant of anti-morphine monoclonal antibody

[0082] Example of Affinity Determination Using Antibody Competitive Binding to Antigen

[0083] ① Dilute the morphine monoclonal antibody (MOP-BSA) to 1 μg / ml with carbonate buffer solution with a pH of 9.6 and a concentration of 0.05M, and then add 100 μl of diluted morphine artificial antigen to each well of a 96-well microtiter plate, Coat overnight at 4°C (2 plates); then wash the plate 3 times with PBS buffer containing 0.05% Tween-20 and pat dry; ② Add 200 μl 0.01mol / L pH7.2 phosphate containi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Affinity constantaaaaaaaaaa
Affinity constantaaaaaaaaaa
Affinity constantaaaaaaaaaa
Login to View More

Abstract

The invention provides a hybridoma cell strain MOP1.0 capable of generating an anti-morphine monoclonal antibody, wherein the cell strain is preserved in China Center for Type Culture Collection with a preservation number of CCTCCNO. C2013159. The invention also provides the anti-morphine monoclonal antibody secreted by the hybridoma cell strain MOP1.0. The invention also provides a kit for detecting morphine in saliva. The invention further provides a detection method and a manufacturing method of the morphine detection kit. The hybridoma cell strain MOP1.0 has the benefit that the artificial antigen of obtained morphine keeps the structural specificity of morphine by utilizing ethyl bromoacetate as a cross-linking agent to activate the morphine. Through the adoption of a sandwich immune method, the using amount of antigens is effectively reduced, and the immunization time is shortened. The hybridoma cell strain MOP1.0 is high in secretion yield, and the anti-morphine monoclonal antibody obtained through secretion of the hybridoma cell strain MOP1.0 has the characteristics of high affinity, high specificity and high sensitivity. A detection product provided by the invention is more advantageous in the aspects of sensibility, specificity, detection limit and the like.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Owner HANGZHOU CLONGENE BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products